Additional Information for Aspergillosis
MMWR Articles:
Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children. MMWR Recommendations and Reports, September 04.2009/58(RR111);1-166.
Guidelines for Preventing Health-Care--Associated Pneumonia, 2003. MMWR Recommendations and Reports, March 26,2004/53(RR03);1-36.
Guidelines for Prevention of Nosocomial Pneumonia. MMWR Recommendations and Reports, January 03, 1997/46(RR-1);1-79.
Aspergillus Endophthalmitis in Intravenous-Drug Users – Kentucky. MMWR Weekly, January 26, 1990/39(3);48-49.
Publications:
Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-60.
Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 2006; 173: 707-717.
Steinbach WJ, Stevens DA. Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis. Clin Infect Dis 2003; 37 (suppl. 3): S157-187.
Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-415.
Marr KA, Patterson T, Denning DW. Aspergillosis: pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 2002; 16: 875-894.
Warnock DW, Hajjeh RA, Lasker BA. Epidemiology and prevention of invasive aspergillosis. Curr Infect Dis Rep 2001; 3: 507-516.
Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis 2000; 30: 696-709.
Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-350.
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC–INFO


